378 related articles for article (PubMed ID: 2442262)
1. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
Raychaudhuri S; Saeki Y; Fuji H; Kohler H
J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones.
Saeki Y; Chen JJ; Shi LF; Kohler H
J Immunol; 1989 Apr; 142(8):2629-34. PubMed ID: 2522964
[TBL] [Abstract][Full Text] [Related]
6. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
7. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
8. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
[TBL] [Abstract][Full Text] [Related]
9. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
[TBL] [Abstract][Full Text] [Related]
10. Characterization of "regulatory" idiotope-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA).
Saeki Y; Chen JJ; Shi LF; Raychaudhuri S; Köhler H
J Immunol; 1989 Feb; 142(3):1046-52. PubMed ID: 2783599
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
Savelyeva N; King CA; Vitetta ES; Stevenson FK
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
[TBL] [Abstract][Full Text] [Related]
13. Idiotype-specific T helper clones recognize a variable H chain determinant.
Saeki Y; Chen JJ; Shi LF; Okuda Y; Köhler H
J Immunol; 1990 Mar; 144(5):1625-8. PubMed ID: 1689751
[TBL] [Abstract][Full Text] [Related]
14. Idiotype matching: correlation of expression of protective idiotype in sera with survival of tumor mice.
Chen JJ; Saeki Y; Köhler H
J Immunol; 1990 Jan; 144(2):759-64. PubMed ID: 2295810
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s).
Wardzala AM; Bowen MB; Jendrisak GS; Bellone CJ
J Mol Cell Immunol; 1986; 2(5):243-53. PubMed ID: 2978231
[TBL] [Abstract][Full Text] [Related]
16. Sporadic idiotypic cross-reactivities between antibodies and T helper cells: one example of aleatory expression of T cell idiotypes.
Martinez C; Coutinho A; Bandeira A; de la Hera A; Toribio M; Marcos MA; Pereira P
J Mol Cell Immunol; 1987; 3(1):21-8. PubMed ID: 2978237
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of idiotype suppression. V. Anti-idiotype antibody inhibits early B cell triggering induced by antigen.
Kim BS; Massey PB; Hui KM
J Immunol; 1983 Feb; 130(2):596-601. PubMed ID: 6600243
[TBL] [Abstract][Full Text] [Related]
18. Recognition of idiotypes in lymphocyte interactions. I. Idiotypic selectivity in the cooperation between T and B lymphocytes.
Hetzelberger D; Eichmann K
Eur J Immunol; 1978 Dec; 8(12):846-52. PubMed ID: 83234
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotype antibodies: an alternative approach to tumor immunotherapy.
Raychaudhuri S
Indian J Exp Biol; 1989 Aug; 27(8):671-80. PubMed ID: 2699310
[TBL] [Abstract][Full Text] [Related]
20. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2.
Raychaudhuri S; Kang CY; Kaveri SV; Kieber-Emmons T; Köhler H
J Immunol; 1990 Jul; 145(2):760-7. PubMed ID: 2164069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]